Pure Global AI
CDSCO UID MFG/IVD/2021/000021_e9663d87490682cde2b73488e331109f_3c44272f2af3d99ab282780d6857a4db

Reagent Red Cells of Group B for ABO Reverse Grouping

TULIP DIAGNOSTICS PRIVATE LIMITEDDevice Class Class DIndia CDSCOBrand: RPR
VerifiedCDSCO · official registry
Registration details
UID
MFG/IVD/2021/000021_e9663d87490682cde2b73488e331109f_3c44272f2af3d99ab282780d6857a4db
Device class
Class D
Brand name
RPR
License holder
TULIP DIAGNOSTICS PRIVATE LIMITED
Approving authority
Sub Zonal Goa
Product information
Matrix Erygen-B comprises of a 0.8% reagent red blood cells of B suspended in an isotonic medium containing a preservative which is employed in the confirmation of the results of forward grouping
About this record

Reagent Red Cells of Group B for ABO Reverse Grouping is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000021_e9663d87490682cde2b73488e331109f_3c44272f2af3d99ab282780d6857a4db. This device is marketed under the brand name RPR. The license holder is TULIP DIAGNOSTICS PRIVATE LIMITED, and it is classified as Device Class Class D. The approving authority is Sub Zonal Goa.

This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.